vTv Therapeutics (VTVT) Cash from Financing Activities (2014 - 2025)

vTv Therapeutics (VTVT) has 12 years of Cash from Financing Activities data on file, last reported at -$321000.0 in Q4 2025.

• For the quarter ending Q4 2025, Cash from Financing Activities changed N/A year-over-year to -$321000.0; the trailing twelve-month figure through Dec 2025 stood at $77.4 million (up 47.21% YoY), and the FY2025 full-year result was $77.4 million, up 47.21% from the prior year.
• Cash from Financing Activities declined to -$321000.0 in Q4 2025, from $77.8 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $77.8 million in Q3 2025 to a low of -$321000.0 in Q4 2025.
• A 5-year average of $11.5 million and a median of $4.4 million in 2022 frame the typical range for Cash from Financing Activities.
• Peak annual rise in Cash from Financing Activities reached 4711.72% in 2023, while the deepest fall reached 107.69% in 2023.
• Tracing VTVT's Cash from Financing Activities over 5 years: stood at $266000.0 in 2021, then soared by 1278.57% to $3.7 million in 2022, then sank by 107.69% to -$282000.0 in 2023, then jumped by 973.4% to $2.5 million in 2024, then plunged by 113.03% to -$321000.0 in 2025.
• Business Quant data shows VTVT's Cash from Financing Activities at -$321000.0 in Q4 2025, $77.8 million in Q3 2025, and -$42000.0 in Q2 2025.